The federal government will not immediately prioritize recovering over $170 million in funding spent on a Quebec-based COVID-19 vaccine manufacturing factory that was recently shut down by its parent company, says Industry and Innovation Minister François-Philippe Champagne.
Medicago Inc., the manufacturer of the plant-based COVID vaccine, Covifenz, announced on Feb. 3 that it will be closing after its parent company, Mitsubishi Chemical Group (MCG), cut all future investments in the company.
